MedTrace Logo

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

NCT06207864 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1001

Last updated 2025-11-13

No results posted yet for this study

Summary

This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.

Conditions

  • Malignant Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of tissue, blood, saliva, and stool samples

PROCEDURE

Return of Results

Receive results

OTHER

Survey Administration

Surveys and Interviews

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • New Mexico Cancer Research Alliance

    lead OTHER

Principal Investigators

  • Cheryl Willman, MD · University of New Mexico Comprehensive Cancer Center

  • Nicole Hamblet · University of New Mexico Comprehensive Cancer Center

  • Andrew Sussman, PhD · University of New Mexico Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-22
Primary Completion
2028-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06207864 on ClinicalTrials.gov